+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

A case-control study of risk factors for myelodysplastic syndromes



A case-control study of risk factors for myelodysplastic syndromes



Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi 25(12): 705-709



To determine the risk factors involved in myelodysplastic syndromes (MDS). A 1:2 case-control study was conducted in 20 Shanghai' hospitals over a 3-year period, covering 266 "de novo" MDS cases corresponded to FAB criteria, and 532 age- and gender-matched controls from same hospitals with MDS cases. Subjects were all surveyed using the same standard questionnaire including histories of medications (Chloramphenicol, Sulfonamides, Meprobamate, Phenytoin, Colchicine, Cyclophosphamide, Propylthiouracil, Anti-TB medication, Tolbutamide, Primaquine and Chinese traditional herbs such as Bezoar, Angelica, Arsenic, Thunder cloud vine) at least 5 years prior to the onset of the disease, tumors, exposure to benzene, heavy metal, organic phosphates, pesticides, petrol/diesel, organic solvents, dye and hair dye products, radiation, house decorating, alcohol and smoking. Occupational exposure to benzene increased significantly the risk of MDS (OR: 8.52, 95% CI: 2.30 - 31.10). Living near high voltage power lines (100 m) increased significantly the risk of MDS (OR: 1.60, 95% CI: 1.10 - 2.32). House decorating (one year prior to the onset of the disease) increased significantly the risk of MDS (OR: 2.40, 95% CI: 1.38 - 4.14). Other investigated occupational poisons did not increase significantly the risk of MDS. Hair dye products, alcohol and smoking did not increase significantly the risk of MDS. Occupational exposure to benzene, living near high voltage power lines and house decorating are the risk factors of MDS.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 051097770

Download citation: RISBibTeXText

PMID: 18230297


Related references

Risk factors of myelodysplastic syndromes: a case-control study. Leukemia 19(11): 1912-1918, 2005

Risk factors for myelodysplastic syndromes: A case-control study in Greece. Cancer Causes & Control 13(7): 603-608, 2002

Risk Factors for Myelodysplastic Syndromes: A Case-Control Study in Greece. Cancer Causes & Control 13(7): 603-608, 2002

Case-control study of risk factors of myelodysplastic syndromes according to World Health Organization classification in a Chinese population. American Journal of Hematology 86(2): 163-169, 2011

Alcohol consumption and risk of myelodysplastic syndromes: a case-control study. Cancer Causes and Control 27(2): 209-216, 2016

Exposure to occupational and environmental factors in myelodysplastic syndromes. Preliminary results of a case-control study. Leukemia 9(4): 693-699, 1995

Smoking as a risk factor for myelodysplastic syndromes and acute myeloid leukemia and its relation to cytogenetic findings: a case-control study. Leukemia Research 33(6): 788-791, 2008

Coalesced multicentric analysis of 2,351 patients with myelodysplastic syndromes indicates an underestimation of poor-risk cytogenetics of myelodysplastic syndromes in the international prognostic scoring system. Journal of Clinical Oncology 29(15): 1963-1970, 2011

Does thrombocytosis alter the, prognosis of myelodysplastic syndromes (MDS) and MDS/myeloproloferative syndromes (MDS/MPD)? A matched case-control analysis of outcomes. 2007

The prognostic value of monosomal karyotype (MK) in higher-risk patients with myelodysplastic syndromes treated with 5-Azacitidine: A retrospective analysis of the Hellenic (Greek) Myelodysplastic syndromes Study Group. American Journal of Hematology 93(7): 895-901, 2018

Epidemiology and risk factors for infections in myelodysplastic syndromes. Transplant Infectious Disease 15(6): 652-657, 2014

Risk factors and their relationship to prognosis in myelodysplastic syndromes. Leukemia Research 22(SUPPL 1): S3-S6, 1998

Prognostic factors and risk models in myelodysplastic syndromes. Clinical Lymphoma, Myeloma and Leukemia 13 Suppl 2: S295-S299, 2014

Risk factors in lacunar syndromes: a case-control study. Acta Neurologica Scandinavica 77(1): 22-26, 1988

Smoking and alcohol intake as risk factors for myelodysplastic syndromes (MDS). Leukemia Research 34(1): 1-5, 2010